Mydecine Innovations Group, Inc. (TSE:MYCO) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Mydecine Innovations Group Inc. has requested a Management Cease Trade Order to allow additional time to finalize their 2023 financial statements and accompanying documents, which were delayed due to a restatement of prior financials and an auditor change. The company expects to complete the filings by June 28, 2024, and will issue bi-weekly status reports until the filings are complete, while adhering to a trading blackout and alternative reporting guidelines.
For further insights into TSE:MYCO stock, check out TipRanks’ Stock Analysis page.